delta 8 and semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF STEP-HFpEF DM randomised trials Health Canada approves 1st generic

With Mounjaro on the way in 2024 a similar drug, using tirzepatide, thats supposedly even more powerful a revolution seems underway, one where obesity has been conquered by pharmaceuticals once and for all

Zepbound targets specific muscle receptors to enhance muscle mass while reducing body fat

For those comfortable with injections, Zepbound stands as a robust choice, particularly for managing obesity or weight concerns related to conditions like high cholesterol or type 2 diabetes

This does not invalidate the research, but it does mean independent replication and broader academic study remain important

Pediatr Neurol

Clin Kidney J 15(8):15931600